Health · Healthcare & Policy · 8 hrs ago
Hospitals sue to block planned 340B drug rebate pilot
The American Hospital Association, a Maine hospital lobby and four safety-net hospitals have sued the US Department of Health and Human Services over a planned 340B drug rebate pilot.
The 340B program, created by Congress in 1992, lets eligible providers buy outpatient medicines at steep discounts so they can support care for low-income and uninsured patients.
The pilot would replace discounts at the time of purchase with rebates paid later, meaning hospitals would first have to pay for the drugs.
The hospitals say this could create heavy administrative costs and put pressure on their finances; they argue the government underestimated those costs.
Drugmakers have criticized the program, saying some hospitals profit unfairly from it, while hospitals say it helps them serve vulnerable communities.
A judge struck down an earlier rebate pilot after a previous hospital lawsuit, and the agency later proposed a revised version.
The hospitals are asking a court in Maine to pause the new pilot, which is scheduled to begin in January, while their legal challenge proceeds.
The American Hospital Association, a Maine hospital lobby and four safety-net hospitals sued the federal government to block a planned 340B drug rebate pilot.
The hospitals say switching from upfront discounts to post-purchase rebates would threaten their financial viability and impose high administrative costs.
They asked a court to halt the pilot, which is scheduled to begin in January, while the legal challenge proceeds.
The complaint says the program’s true administrative costs could exceed $1 billion a year, compared with the government’s estimate of $537 million.
This is the second time hospitals have sued over an attempt to introduce a 340B rebate program.
- Who
- The American Hospital Association, a Maine hospital lobby and four safety-net hospitals.
- What
- They sued to block a federal pilot that would replace upfront 340B drug discounts with post-purchase rebates.
- When
- The complaint was filed Friday; the pilot is scheduled to begin in January.
- Where
- The complaint was filed in Maine district court.
- Why
- The hospitals say the rebate system would impose high costs and administrative burdens and threaten their financial viability.
Hospitals
Pharmaceutical companies
Program impact
Hospitals
Hospitals say rebates would impose unsustainable costs and threaten their ability to care for vulnerable patients.
Pharmaceutical companies
Drugmakers argue that hospitals unjustly profit from the program and that some use illegal duplicate discounts to increase savings.
Congress created the 340B program to help eligible providers buy outpatient drugs at steep discounts.
A judge struck down HRSA’s initial attempt to launch a rebate pilot after a lawsuit by the AHA and the Maine Hospital Association.
HRSA announced a revised rebate program covering more manufacturers and drugs than its first attempt.
The AHA, a Maine hospital lobby and four safety-net hospitals filed a new complaint challenging the pilot.
The rebate pilot is scheduled to begin.
- Complaint filed
- Maine district court
- Hospitals suing
- American Hospital Association, a Maine hospital lobby and four safety-net hospitals
- HRSA annual cost estimate
- $537 million
- Hospitals’ estimate of true annual administrative costs
- Could exceed $1 billion
- Pilot start
- January
What people are saying
HRSA’s cost analysis was “egregiously flawed
the effects of the rebate program would be “devastating
Maine hospitals cannot afford this Rebate Program.







